Progress in rare diseases research 2010–2016: an IRDiRC perspective

Abstract

In 2011, the International Rare Diseases Research Consortium (IRDiRC) was formed to unite public and private sector funders of research, patient advocacy groups, and scientific researchers to advance rare diseases research worldwide. Six years after its official launch, IRDiRC is now reflecting on its progress and achievements toward its ambitious goals for the rare diseases research collective – to develop 200 new therapies and the means to diagnose most rare genetic diseases by the year 2020.

This article is protected by copyright. All rights reserved

http://ift.tt/2voZwc5